Is Cognition Therapeutics, Inc. overvalued?

Cognition Therapeutics, Inc. (CGTX) — key valuation metrics and fundamentals.

No verdict

Price

$1.01

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$90.4M

Dividend yield

0.0%

Return on equity

-50.2%

Sector

Healthcare

Fair value compares CGTX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Aug 2026.

Related stocks